Advisors Asset Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Advisors Asset Management’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-17,161	Closed	-$2.97M	–	1873
2015 Q1	$2.97M	Buy	17,161 +1,943	+13%	+$285K	0.04%	527
2014 Q4	$1.75M	Buy	15,218 +5,277	+53%	+$639K	0.02%	692
2014 Q3	$1.55M	Buy	9,941 +3,504	+54%	+$508K	0.02%	690
2014 Q2	$794K	Buy	6,437 +1,625	+34%	+$180K	0.01%	893
2014 Q1	$499K	Buy	4,812 +377	+9%	+$38.6K	0.01%	995
2013 Q4	$399K	Buy	4,435 +1,599	+56%	+$128K	0.01%	1025
2013 Q3	$190K	Buy	2,836 +2,046	+259%	+$141K	﹤0.01%	1143
2013 Q2	$52K	Buy	+790	New	+$45.2K	﹤0.01%	1520

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Advisors Asset Management's SLXP Position: Q2 2015 in Review

Advisors Asset Management sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 17,161 shares — an estimated $2.97M sold.

Advisors Asset Management first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $2.97M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Advisors Asset Management reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Advisors Asset Management sold 17,161 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $2.97M.
Advisors Asset Management first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
Advisors Asset Management's SALIX PHARMACEUTICALS LTD DEL position peaked at $2.97M in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Advisors Asset Management's 13F filing for Q2 2015, filed 11 Aug 2015.